Table 2 Healthcare resource use
Diagnosis | ECH (n = 89) | CCH (n = 19) | Total (n = 108) | p-value |
|---|---|---|---|---|
Headache centre visits, n. | 2.2 ± 0.7 (1–5) | 6.7 ± 1.5 (4–9) | 3.0 ± 1.9 (1–9) | < 0.0001 |
Cardiology visits, n. (%) patients | 10 (11.2) | 13 (68.4) | 23 (21.3) | < 0.0001 |
ED visits, n. (%) patients | 14 (15.7) | 11 (57.9) | 25 (23.1) | < 0.0001 |
ED visits, n. per patient | 0.2 ± 0.6 (0–3) | 0.7 ± 0.7 (0–2) | 0.3 ± 0.6 (0–3) | 0.000 |
ECG, n. (%) patients | 53 (59.6) | 18 (94.7) | 71 (65.7) | 0.002 |
ECG, n. per patient | 0.6 ± 0.7 (0–3) | 2.5 ± 1.2 (0–4) | 0.9 ± 1.1 (0–4) | < 0.0001 |
Brain MRI, n. (%) patients | 21 (23.6) | 16 (84.2) | 37 (34.3) | < 0.0001 |
Brain MRI, n. per patient | 0.2 ± 0.4 (0–1) | 0.8 ± 0.4 (0–1) | 0.3 ± 0.5 (0–1) | < 0.0001 |
Acute medications, n. (%) | ||||
Sumatriptan 6 mg | 56 (62.9) | 17 (89.5) | 73 (67.6) | 0.030 |
Zolmitriptan 5 mg | 19 (21.3) | 1 (5.3) | 20 (18.5) | N.S. |
Oxygen | 71 (79.8) | 19 (100) | 90 (83.3) | 0.038 |
Combinations | 57 (64) | 18 (94.7) | 75 (69.4) | 0.007 |
Transitional treatments, n. (%) | ||||
Oral corticosteroids | 29 (32.6) | 0 (0) | 29 (26.9) | 0.002 |
G.O.N. block | 8 (9) | 15 (78.9) | 23 (21.3) | < 0.0001 |
Preventive medications, n. (%) | ||||
Verapamil | 62 (69.7) | 15 (78.9) | 77 (71.3) | N.S. |
Topiramate | 30 (33.7) | 11 (57.9) | 41 (38) | 0.048 |
Combinations | 51 (57.3) | 18 (94.7) | 69 (63.9) | 0.001 |
Nutraceutics, n. (%) | ||||
Melatonin | 31 (34.8) | 17 (89.5) | 48 (44.4) | < 0.0001 |